Vivera Pharmaceuticals, Inc. - Vivera Pharmaceuticals Inc.

About Vivera

Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supplies, medical technologies, and neurosciences, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.

We Put Patients First

Vivera is committed to the continued research and development of innovative therapies across the spectrum. We believe that now is the time to combat some of the most unprecedented issues affecting patients and their caregivers by redefining the landscape with safe, yet effective, non-addictive treatment alternatives for pain management and the latest in medical device technologies. From strength in vision to channeled realization, we believe the path forward begins with the requirement to put patients first. Our foremost mission is to enhance the lives of millions of neighbors, families, and the leaders of tomorrow, through ceaseless development of life-changing new therapies.

Making A Difference

Vivera is dedicated to making a positive difference for vulnerable communities across the world. Through our non-profit organization, Vivera Cares, we are helping underserved communities, like Tribal Nations and frontline workers, access the resources they need to keep their communities safe and healthy. With our continued support, we can envision a brighter future for our communities, patients, and providers.

Press Releases

Vivera is Attending the 2021 MHA Business Summit

March 22, 2021

Vivera is excited to announce that we will be sponsoring the 17th MHA Business Summit taking place March 24-25, 2021. The MHA Business Summit is

TABMELT® Granted Patent Rights in Russia, Expanding Vivera Global Licensing

February 25, 2021

NEWPORT BEACH, Calif., Feb. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, Inc., is pleased to announce the expansion of its exclusive global licensing of the novel

Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative

January 25, 2021

NEWPORT BEACH, Calif., Jan. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern

Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management

November 25, 2020

NEWPORT BEACH, Calif., Nov. 25, 2020 /PRNewswire/ — Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of

Vivera Pharmaceuticals Welcomes Gerald A. Maguire, MD to Advisory Board

November 24, 2020

NEWPORT BEACH, Calif., Nov. 24, 2020 /PRNewswire/ — Vivera Pharmaceuticals is pleased to announce the appointment of Dr. Gerald A. Maguire, Professor and Chair of

Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations

November 18, 2020

NEWPORT BEACH, Calif., Nov. 18, 2020 /PRNewswire/ — Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera’s BioZone, an advanced

veteran with ptsd and opioid use disorder

Understanding the Relationship Between PTSD and Opioid Use Disorder

April 5, 2021

Post-traumatic stress disorder (PTSD) is a mental health problem people can develop after witnessing or experiencing a life-threatening event. PTSD can affect anyone, but certain

The Three Waves of the Opioid Epidemic

April 1, 2021

The opioid epidemic refers to the dramatic increase in prescription and non-prescription use in the U.S. It also encompasses the opioid-related overdoses that resulted from

Opioid Misuse: What You Should Know

April 1, 2021

Opioids are safe for most people when taken as prescribed for a short period. Unfortunately, many people misuse these medications to achieve a euphoric effect.

4 Reasons Why Sleep Worsened During the Pandemic

March 26, 2021

Getting enough sleep is essential for your immune system to function optimally. Adequate sleep is associated with a reduced risk of infection and an improved

A Brief History of the Opioid Epidemic

March 26, 2021

In 1775, opium made its way to the U.S. In the 1800s, people used opioids to treat everyday ailments, from coughs to chronic pain. During

The-Impact-COVID-Had-on-Mental-Health-in-the-U.S

How COVID-19 Negatively Affected Mental Health

March 26, 2021

Mental health has been a topic of interest for a while. For years, the prevalence of anxiety, depression, and suicidal ideation in the U.S has

DIVISIONS

Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.

Patents, pending and licensed.

Vivera is working to change the future of drug delivery, medical device, and medical technologies at home and across the globe with its extensive intellectual property portfolio.

About Vivera

We Put Patients First

Making A Difference

Press Releases

Vivera is Attending the 2021 MHA Business Summit

TABMELT® Granted Patent Rights in Russia, Expanding Vivera Global Licensing

Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative

Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management

Vivera Pharmaceuticals Welcomes Gerald A. Maguire, MD to Advisory Board

Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations

Blog

Understanding the Relationship Between PTSD and Opioid Use Disorder

The Three Waves of the Opioid Epidemic

Opioid Misuse: What You Should Know

4 Reasons Why Sleep Worsened During the Pandemic

A Brief History of the Opioid Epidemic

How COVID-19 Negatively Affected Mental Health

Vivera is Proudly Partnered With: